98%
921
2 minutes
20
Among Rochester NY children, a dramatic increase in nasopharyngeal (NP) colonization by non-vaccine pneumococcal serotypes 35B and 15A occurred during years 2010-2015, after introduction of 13-valent pneumococcal conjugate vaccine (PCV13). In our population, serotype 35B strains colonized in the nasopharynx (NP) but infrequently caused acute otitis media (AOM) whereas serotype 15A strains displayed virulence, evidenced by causing AOM. To explain the virulence difference, virulence genes expression between 35B and 15A, as well as the host's immune response during asymptomatic colonization were analyzed. We investigated differences in regulation of 19 virulence genes for differences in virulence using RT-PCR in 20 35B and 14 15A strains and measured gene expression of 9 host innate cytokines in the NP to assess the mucosal inflammatory response during asymptomatic colonization. Comparing 35B versus 15A strains, genes for competence ComA and RrgC were upregulated; capsular (Cps2D) and virulence genes (PfbA, PcpA and PhtE) were downregulated among 35B strains. PavB, LytA, LytB, NanA, CiaR, PhtD, LuxS, PspA and pneumolysin (Ply) showed no difference. IL17 and IL23 gene expression were > tenfold higher during 35B compared to 15A strain asymptomatic colonization. Only IL23 showed significant difference. In the first 5 years after introduction of PCV13, serotype 35B strains emerged as asymptomatic colonizers and 15A strains emerged to cause AOM in young children. Various genes (PfbA, PcpA, Cps2D and PhtE) among tested in this analysis were downregulated in 35B whereas ComA and RrgC were significantly upregulated. For the host's cytokine response, IL23 proinflammatory response which is essential for the differentiation of Th17 lymphocytes in the NP of children with 35B strains was significantly higher than the response to 15A during asymptomatic colonization.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00430-021-00701-w | DOI Listing |
J Antimicrob Chemother
August 2025
Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E 0J9.
Objectives: To compare the antimicrobial resistance and serotype patterns in Streptococcus pneumoniae collected from blood cultures and respiratory specimens in Canada from 2007 to 2023.
Methods: S. pneumoniae isolates were submitted from Canadian hospitals as part of the ongoing national surveillance study, CANWARD.
Microbiol Spectr
September 2025
Department of Bacteriology 1, National Institute of Infectious Diseases, Tokyo, Japan.
serotype 35B, a nonvaccine serotype, is common among clinical pneumococcal isolates in Japan after vaccination. We report the emergence of serotype 35B sequence type 156 (35B-ST156), a rare type previously reported in Japan, in isolates from patients at a hospital. Multilocus sequence typing of serotype 35B isolates from 2014 to 2023 revealed that 35B-ST156 appeared in 2019 and was the most common sequence type of 35B in 2023.
View Article and Find Full Text PDFFront Microbiol
April 2025
Microbiology Department, Laboratori Clínic Metropolitana Nord, Germans Trias i Pujol University Hospital, Badalona, Spain.
is the leading cause of community-acquired pneumonia and remains a significant contributor to bacteremia and meningitis, collectively known as invasive pneumococcal disease (IPD). Certain serotypes are more strongly associated with severe illness and antimicrobial resistance. Accurate serotyping is essential for effective IPD surveillance and vaccine development.
View Article and Find Full Text PDFPediatr Infect Dis J
May 2025
IAME EVRest, INSERM UMR1137, Paris.
Background: Children with sickle cell disease (SCD) are susceptible to invasive bacterial infections, particularly those caused by Streptococcus pneumoniae . Data concerning nasopharyngeal carriage remain scarce in this population at high risk of resistant bacteria owing to antibiotic pressure and frequent hospitalizations.
Methods: We conducted this prospective trial, DREPANOBACT, in 7 French hospitals to assess the nasopharyngeal carriage rate for S.
New Microbes New Infect
December 2024
Department of Hygiene, Sapporo Medical University School of Medicine, Sapporo, Japan.
Background: The prevalence of serotypes and antimicrobial resistance of was characterized among children thirteen years after the licensure of the pneumococcal conjugate vaccine (PCV) in Japan.
Methods: A total of 353 pneumococcal isolates were collected from Japanese children between March and July 2023. All the isolates were serotyped using genetic methods and tested for susceptibility to 14 antimicrobial agents.